DuPont Names McKinsey's David G. Bills Vice President of Corporate Plans
DuPont today announced the appointment of David G. Bills, 39, as vice president – Corporate Plans, effective May 1.
Bills is currently a partner in the Chicago office of McKinsey & Company, providing strategic guidance and consultation on a wide range of issues facing major industrial and technology companies.
"The breadth of Dave's experience and his proven track record in strategic planning, mergers and acquisitions, and marketing for major corporations make him an ideal fit for DuPont," said John W. Himes, DuPont senior vice president for Corporate Strategy. "We expect him to make an extremely strong contribution to the company's sustainable growth mission as the leader of our Corporate Plans function."
At McKinsey, Bills has served as co-leader of the firm's worldwide Growth Strategy Practice and is a member of the Chemicals and Corporate Strategy Practices. He also was the founder of the McKinsey Business-to-Business Marketing Practice. Prior to McKinsey, Bills was employed by Exxon.
He has a bachelor's degree in chemical engineering from the University of Wisconsin and an MBA from the Harvard Graduate School of Business.
Most read news

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
WACKER ends 2017 with Substantial Sales and Earnings Growth

The Chemistry of Gunpowder
Intricate, curving 3D nanostructures for biological and materials applications
